Page 561 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 561

CHAPTER 25  Tumors of the Skeletal System  539



           Nonsurgical Limb Salvage                                        H                          H
           Intracorporeal and Extracorporeal Intraoperative
  VetBooks.ir  Radiation Therapy
           Intraoperative RT (IORT), using either an intracorporeal or extra-
           corporeal approach, for limb sparing has been utilized in a small
           number of canine OSA patients 225,226  as well as human patients
           with extremity bone tumors. 227–229  This limb salvage technique
           involves a surgical approach to the bone with osteotomy proxi-
           mal or distal to the affected site (depending on the anatomic loca-
           tion of the tumor) and reflection of normal soft tissues from the
           tumor affected bone. The neurovascular bundle, muscle, and skin
           are retracted away from the affected bone, and the tumor is piv-    8.56 cm                      8.57 cm
           oted from the site on the intact joint tissue. The patient is then
           transported to the radiation suite and a single dose of 70 Gy is   F                       F
           then delivered to the tumor, taking care to spare the distracted
           neurovascular bundle. The irradiated bone is then anatomically   • Fig. 25.9  Dose color wash map of radiation distribution for stereotactic
           replaced and surgical fixation of the osteotomy is achieved with   radiation therapy of distal radius osteosarcoma lesion showing a steep
           either dynamic compression plating or an interlocking nail sys-  dose gradient drop off between tumor volume and normal tissues.
           tem. One advantage of IORT for limb salvage over LSS is that it
           can be used to preserve limb and joint function in anatomic sites   MST  was  9.7  months.  Of  the  patients  with  complete  medical
           that are not amenable to LSS with arthrodesis of the adjacent joint   records, 63% developed pathologic fracture at a median of 5.9
           (e.g., proximal humerus). 162  Patients treated with IORT had good   months. Acute and late skin toxicities developed in 58% and 16%
           limb function in the immediate postoperative period; however,   of dogs, respectively. Involvement of subchondral bone appeared
           complications related to surgery or RT led to implant revisions   to be predictive of shortened time to fracture.
           in 69% of cases within 5 to 9 months of initial surgery, including   Many veterinary radiation oncology facilities currently offer
           four amputations. Pathologic fracture of the irradiated bone was   SRT for OSA. SRT protocols for the treatment of OSA typically
           the most common complication. Additionally, local tumor recur-  involve two to three fractions with doses ranging from 8 to 13 Gy
           rence occurred in four dogs and infection in four dogs. A modi-  per fraction, and the most common protocol is three fractions of
           fication of this technique includes complete temporary removal   10 Gy. These fractions are delivered daily or, less commonly, every
           of diaphyseal tumors, performing extracorporeal IORT, and then   other day.
           reimplantation and stabilization of the irradiated bone segment.   In an orthotopic, athymic, rat model inoculated with canine
           In situ radiation of distal femur and any tibial tumors can be per-  OSA cells, three fractions of 12 Gy SRT was shown to induce
           formed without osteotomy. The disease-free and overall limb and   complete tumor necrosis in 92% of rats treated. 232  Previous
           joint salvage rates for extracorporeal IORT as assessed at the time   canine studies have indicated that therapies which induce more
           of death or data analysis were 46% and 54%, respectively. The   than 80% local tumor necrosis are associated with an increase in
           MST for dogs with appendicular sarcoma treated with limb- and   local tumor control. 233  The same athymic rat model also indicated
           joint-sparing extracorporeal IORT was 298 days.       that zoledronic acid combined with parathyroid hormone could
                                                                 increase bone volume after SRT. Many oncologists advocate the
           Stereotactic Radiation Therapy                        use of bisphosphonates before or after SRT. As SRT is a local-
           SRT or stereotactic radiosurgery (SRS) offer the ability to deliver   ized therapy, adjuvant chemotherapy is recommended to delay the
           high dose RT to the tumor volume with relative sparing of the   onset of metastatic disease. Chemotherapy can also be considered
           surrounding normal tissues by use of accurate patient immobili-  as a radiation sensitizer as reported in the studies of single frac-
           zation, image guidance, and a rapid dose fall-off from the tumor   tion SRS for canine OSA. 231  Radiation recall (recurrence of acute
           margins (Fig. 25.9). In this respect, it is a refinement of the IORT   skin toxicities after initial resolution) has been observed in some
           technique that avoids the need for surgical exposure. A nonsurgical   patients treated with adjuvant DOX chemotherapy.
           limb salvage technique using a single fraction SRS was developed   Pathologic fracture is the most frequent complication associ-
           at the University of Florida, and initial results were reported in 11   ated with SRT and SRS. Fracture is postulated to be due to the
           dogs. 230  Adjuvant carboplatin chemotherapy was used in six dogs   amount of preexisting tumor associated osteolysis and postirra-
           immediately before RT for its potential radiosensitization action   diation bone necrosis resulting in loss of dynamic bone remodel-
           in addition to its conventional cytotoxic effects, and five dogs were   ing and healing capacity after SRT. Smaller, more blastic lesions
           treated with SRS alone. Four dogs developed pathologic fractures   may be better candidates for SRT limb salvage than larger, more
           and one dog developed infection. Acute effects to the skin were   lytic lesions. There is some evidence that lysis of subchondral
           generally mild to moderate; however, one dog developed an open   bone may be associated with a higher rate of fracture. 231  Patho-
           skin wound 3 months after treatment, and another dog developed   logic fracture has been treated by internal fixation, external
           a full thickness skin wound under a splint used during the treat-  coaptation, or amputation. 112  Preemptive stabilization has also
           ment of a pathologic fracture. Limb use in the dogs treated with   been used for more concerning lesions or those with evidence
           SRS and chemotherapy was excellent. The overall MST was 363   of pathologic fracture at the time of SRT (Fig. 25.10). 111   In
           days. In a follow-up retrospective study, the same group reported   a recent study, seven dogs underwent surgical stabilization for
           the outcome of 46 patients treated with a similar single fraction   fractures documented at the time of SRT, and 11 dogs were sta-
           SRS technique (median prescribed dose 30 Gy). 231  Forty-five dogs   bilized preemptively. Infection occurred in 15 dogs and was con-
           received conventional maximal tolerated dose chemotherapy. The   sidered a major complication in 13 of these dogs and ultimately
   556   557   558   559   560   561   562   563   564   565   566